Sigma-1 (σ₁) receptor deficiency reduces β-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B

Neuropharmacology. 2015 Feb:89:215-24. doi: 10.1016/j.neuropharm.2014.09.027. Epub 2014 Oct 5.

Abstract

In early Alzheimer's disease (AD) brain, reduction of sigma-1 receptors (σ1R) is detected. In this study, we employed male heterozygous σ1R knockout (σ1R(+/-)) mice showing normal cognitive performance to investigate association of σ1R deficiency with AD risk. Herein we report that a single injection (i.c.v.) of Aβ(25-35) impaired spatial memory with approximately 25% death of pyramidal cells in the hippocampal CA1 region of WT mice (Aβ(25-35)-WT mice), whereas it did not cause such impairments in σ1R(+/-) mice (Aβ(25-35)-σ1R(+/-) mice). Compared with WT mice, Aβ(25-35)-WT mice showed increased levels of NMDA-activated currents (INMDA) and NR2B phosphorylation (phospho-NR2B) in the hippocampal CA1 region at 48 h after Aβ25-35-injection (post-Aβ(25-35)) followed by approximately 40% decline at 72 h post-Aβ(25-35) of their respective control levels, which was inhibited by the σ1R antagonist NE100. In Aβ(25-35)-WT mice, the administration of NR2B inhibitor Ro25-6981 or NE100 on day 1-4 post-Aβ(25-35) attenuated the memory deficits and loss of pyramidal cells. By contrast, Aβ(25-35)-σ1R(+/-) mice showed a slight increase in the INMDA density and the phospho-NR2B at 48 h or 72 h post-Aβ25-35 compared to σ1R(+/-) mice. Treatment with σ1R agonist PRE084 in Aβ(25-35)-σ1R(+/-) mice caused the same changes in the INMDA density and the phospho-NR2B as those in Aβ(25-35)-WT mice. Furthermore, Aβ(25-35)-σ1R(+/-) mice treated with the NMDA receptor agonist NMDA or PRE084 on day 1-4 post-Aβ(25-35) showed a loss of neuronal cells and memory impairment. These results indicate that the σ1R deficiency can reduce Aβ(25-35)-induced neuronal cell death and cognitive deficits through suppressing Aβ(25-35)-enhanced NR2B phosphorylation.

Keywords: Alzheimer's disease (AD); Apoptosis; N-methyl-D-aspartate receptor (NMDAr); Sigma-1 receptor (σ(1)R); Spatial memory; β-Amyloid (Aβ).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Cell Death / drug effects
  • Cognition Disorders* / chemically induced
  • Cognition Disorders* / genetics
  • Cognition Disorders* / pathology
  • Disease Models, Animal
  • Excitatory Amino Acid Agents / pharmacology
  • Hippocampus / pathology*
  • Male
  • Maze Learning / drug effects
  • Membrane Potentials / drug effects
  • Membrane Potentials / genetics
  • Mice
  • Mice, Knockout
  • N-Methylaspartate / pharmacology
  • Neurons / drug effects*
  • Neurons / physiology
  • Peptide Fragments / toxicity*
  • Phosphorylation / drug effects
  • Phosphorylation / genetics
  • Reaction Time / drug effects
  • Reaction Time / genetics
  • Receptors, N-Methyl-D-Aspartate / metabolism*
  • Receptors, sigma / deficiency*
  • Receptors, sigma / genetics
  • Sigma-1 Receptor
  • Spatial Memory / drug effects
  • Time Factors

Substances

  • Amyloid beta-Peptides
  • Excitatory Amino Acid Agents
  • NR2B NMDA receptor
  • Peptide Fragments
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, sigma
  • amyloid beta-protein (25-35)
  • N-Methylaspartate